OWS announces a $1.2 billion investment in the Oxford University vaccine candidate AZD 1222, which is being developed in partnership with AstraZeneca, with an anticipated delivery of 300 million doses in October 2020. Source
OWS announces a $1.2 billion investment in the Oxford University vaccine candidate AZD 1222, which is being developed in partnership with AstraZeneca, with an anticipated delivery of 300 million doses in October 2020. Source